Can levetiracetam (Keppra) be discontinued if the patient has a drug‑related reaction?

Discontinuing Levetiracetam (Keppra) for Drug Reactions

Yes, levetiracetam should be discontinued immediately if a patient develops a drug-related reaction, particularly if there are signs of serious hypersensitivity such as rash, fever with eosinophilia, or behavioral/psychiatric symptoms that impair quality of life. 1

Immediate Discontinuation Indications

Discontinue levetiracetam immediately if any of the following occur:

• Cutaneous reactions: Any bullous or exfoliative skin rash, morbilliform eruptions, or signs of Stevens-Johnson Syndrome/toxic epidermal necrolysis 2, 3
• DRESS syndrome: Fever, rash, eosinophilia, and systemic symptoms (hepatitis, pneumonitis, lymphadenopathy) 3
• Severe psychiatric reactions: Psychotic behavior, severe depression with suicidal ideation, or delirium that impairs function 1, 4, 5
• Unexplained fever with eosinophilia: These may represent early progression to DRESS syndrome 6

Gradual Withdrawal for Non-Emergency Situations

For patients without acute hypersensitivity reactions but requiring discontinuation (e.g., intolerable behavioral side effects, treatment completion), taper gradually to minimize seizure risk. 1

• The FDA label explicitly states: "Antiepileptic drugs, including KEPPRA, should be withdrawn gradually to minimize the potential of increased seizure frequency" 1
• In brain tumor patients who have achieved local tumor control after surgery or treatment regression, tapering and stopping can be considered over weeks 7, 8
• A slow, gradual taper maximizes favorable outcomes 8

Clinical Context for Discontinuation Decisions

Brain Tumor Patients on Seizure Prophylaxis

• If the patient never had a seizure (primary prophylaxis): Discontinuation is appropriate once local tumor control is achieved, as primary prophylaxis is not indicated 7, 9
• If the patient had seizures (secondary prophylaxis): Continue until local control is confirmed, then consider gradual taper 7, 8
• Monitor closely during taper, as worsening seizures may herald tumor progression and warrant repeat MRI 8

Hypersensitivity Reactions

The literature documents several serious levetiracetam-induced reactions despite its reputation as a "benign" antiepileptic:

• DRESS syndrome with pneumonitis and hepatitis resolved with drug withdrawal alone (no corticosteroids required in one case) 3
• Morbilliform rash requiring methylprednisolone, resolving within 4 days of discontinuation 2
• Fever and eosinophilia resolving within 24 hours of stopping levetiracetam 6
• Delirium improving dramatically within 24 hours of the last dose 4

Psychiatric and Behavioral Reactions

• Behavioral symptoms (aggression, irritability, mood disorders) occurred in 5-12.7% of patients in controlled trials 1
• Depression associated with levetiracetam in elderly patients resolved within 4-8 weeks of discontinuation 5
• If psychiatric symptoms significantly impair quality of life or safety, switch to an alternative antiepileptic (lamotrigine, valproate) 7, 9

Alternative Antiepileptic Options

When levetiracetam must be discontinued, preferred alternatives include:

• Lamotrigine: Excellent tolerability but requires several weeks to reach therapeutic levels 7
• Valproic acid: Effective with good overall tolerability, though contraindicated in women of childbearing potential 7
• Avoid enzyme-inducing antiepileptics (phenytoin, carbamazepine, phenobarbital) due to drug interactions and side effects 7, 9

Monitoring During and After Discontinuation

• Serum drug levels can help assess compliance and differentiate drug-related side effects from other causes 8
• Neurology consultation should be obtained if complications arise during taper 8
• Patients and caregivers must receive clear instructions on recognizing and responding to breakthrough seizures 8
• In brain tumor patients, repeat MRI if seizure frequency worsens, as this may indicate tumor progression 8

Common Pitfalls to Avoid

• Do not continue levetiracetam if a very severe life-threatening reaction has occurred 10
• Do not abruptly stop in non-emergency situations, as this increases seizure risk 1
• Do not assume levetiracetam is always benign—serious hypersensitivity reactions, though rare, are well-documented 2, 6, 3
• Do not delay discontinuation when DRESS syndrome is suspected, as early recognition and drug withdrawal are essential to avoid life-threatening complications 11, 3